Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2024

Open Access 01-12-2024 | Human Immunodeficiency Virus | Research

Imprisonment for South Ethiopian people living with HIV presents a double health burden: lived experiences of prisoners

Authors: Terefe Gone Fuge, George Tsourtos, Emma R Miller

Published in: BMC Health Services Research | Issue 1/2024

Login to get access

Abstract

Background

Optimal adherence is crucial for ensuring both therapeutic and preventative benefits of antiretroviral therapy (ART). Sub-optimal adherence is common in prisoners and little information is available about its predisposing circumstances in resource-limited settings. We explored lived experiences of inmates living with HIV (ILWH) and experiential accounts of service providers in South Ethiopia to identify barriers to and facilitators of HIV care use in the prison context.

Methods

We conducted qualitative in-depth interviewing with eleven ILWH and eleven service providers. Audio recorded interview data were transcribed verbatim in Amharic language, translated into English and coded based on emerging concepts. We employed a descriptive phenomenological approach to abstract meaning attributed to the prisoners’ lived experiences in relation to HIV care use and service providers’ experiential account regarding care provision as presented to our consciousness.

Findings

Several concepts emerged as barriers to HIV care use amongst ILWH in South Ethiopia including: limited access to standard care, insufficient health staff support, uncooperative security system, loss of patient privacy, a lack of status disclosure due to social stigma, and food supply insufficiency. In addition to a unique opportunity offered by an imprisonment for some ILWH to refrain from health damaging behaviours, the presence of social support in the prison system facilitated care use.

Conclusions

This study identified important structural and social contexts that can both hinder and enhance HIV care use amongst ILWH in South Ethiopia. Given the disproportionate burden of HIV in prisoners and the potential of transmission to others during and after incarceration, development of contextually-responsive strategies is required to address the barriers and to also strengthen the enablers.
Literature
1.
World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva, Switzerland: WHO; 2013.
2.
World Health Organization (WHO). Adherence to long-term therapies: evidence for action. Human immunodeficiency virus and acquired immunodeficiency syndrome. Geneva, Switzerland: WHO; 2003.
3.
World Health Organization (WHO). Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations: 2016 update. Geneva, Switzerland: WHO; 2016.
4.
Ruperez M, Pou C, Maculuve S, Cedeno S, Luis L, Rodriguez J, et al. Determinants of virological failure and antiretroviral drug resistance in Mozambique. J Antimicrob Chemother. 2015;70(9):2639–47.PubMedCrossRef
5.
Chammartin F, Zrcher K, Keiser O, Weigel R, Chu K, Kiragga AN, et al. Outcomes of patients lost to follow-up in African antiretroviral therapy programs: individual patient data meta-analysis. Clin Infect Dis. 2018;67(11):1643–52.PubMedPubMedCentralCrossRef
6.
Haas AD, Zaniewski E, Anderegg N, Ford N, Fox MP, Vinikoor M, et al. Retention and mortality on antiretroviral therapy in sub-saharan Africa: collaborative analyses of HIV treatment programmes. J Int AIDS Soc. 2018;21(2):e25084.PubMedPubMedCentralCrossRef
7.
8.
Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. The Lancet. 2016;388(10049):1089–102.CrossRef
9.
United Nations Office on Drugs and Crime (UNODC). HIV and AIDS prevention, care, treatment support in prison settings sub-Saharan Africa: Final project report. (2017) Pretoria: UNODC; 2017.
10.
Bick J, Culbert G, Al-Darraji HA, Koh C, Pillai V, Kamarulzaman A, Altice F. Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in Malaysia. Int J Prison Health. 2016;12(4):253–69.PubMedCrossRef
11.
12.
Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther. 2004;9(5):713–9.PubMedCrossRef
13.
Shalihu N, Pretorius L, van Dyk A, Vander Stoep A, Hagopian A. Namibian prisoners describe barriers to HIV antiretroviral therapy adherence. AIDS Care. 2014;26(8):968–75.PubMedCrossRef
14.
Small W, Wood E, Betteridge G, Montaner J, Kerr T. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care. 2009;21(6):708–14.PubMedCrossRef
15.
Roberson DW, White BL, Fogel CI. Factors influencing adherence to antiretroviral therapy for HIV-infected female inmates. J Association Nurses AIDS Care: JANAC. 2009;20(1):50–61.CrossRef
16.
Farhoudi B, Alipour A, Ghodrati S, Seyedalinaghi S, Zanganeh M, Mohraz M. Barriers to adherence to antiretroviral treatment among inmates of a prison in Tehran, Iran: a qualitative study. Archives of Clinical Infectious Diseases. 2018;13(2).
17.
Rodrguez-Daz CE, Rivera-Negrn RM, Clatts MC, Myers JJ. Health care practices and associated service needs in a sample of HIV-positive incarcerated men in Puerto Rico: implications for retention in care. J Int Association Providers AIDS Care. 2014;13(6):492–6.CrossRef
18.
Mostashari F, Riley E, Selwyn PA, Altice FL. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. J Acquir Immune Defic Syndr Hum Retrovirology. 1998;18(4):341–8.CrossRef
19.
Seyed Alinaghi SA, Farhoudi B, Mohraz M, Alipour A, Golrokhy R, Hosseini M, Miri J. Adherence to antiretroviral therapy and tuberculosis treatment in a prison of Tehran, Iran. Infect Disord Drug Targ. 2016;16(3):199–203.CrossRef
20.
Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28(1):47–58.PubMedCrossRef
21.
Soto Blanco JM, Perez IR, March JC. Adherence to antiretroviral therapy among HIV-infected prison inmates (Spain). Int J STD AIDS. 2005;16(2):133–8.PubMedCrossRef
22.
Soto Blanco JM, Ruiz Pérez I, De Labry Lima AO, Castro Recio JM, Girela López E, Antón Basanta JJ. Adherence to antiretroviral treatment in prisons. AIDS Res Hum Retroviruses. 2005;21(8):683–8.CrossRef
23.
Ines SM, Moralejo L, Marcos M, Fuertes A, Luna G. Adherence to highly active antiretroviral therapy in HIV-infected inmates. Curr HIV Res. 2008;6(2):164–70.PubMedCrossRef
24.
Uthman OA, Oladimeji O, Nduka C. Adherence to antiretroviral therapy among HIV-infected prisoners: a systematic review and meta-analysis. AIDS Care-Psychological and Socio-Medical Aspects of AIDS/HIV. 2017;29(4):489–97.
25.
White BL, Wohl DA, Hays RD, Golin CE, Liu H, Kiziah CN, et al. A pilot study of health beliefs and attitudes concerning measures of antiretroviral adherence among prisoners receiving directly observed antiretroviral therapy. AIDS Patient Care & STDs. 2006;20(6):408–17.CrossRef
26.
Chakrapani V, Kamei R, Kipgen H, Kh JK. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users. Int J Prison Health. 2013;9(2):82–91.PubMedCrossRef
27.
Todrys KW, Amon JJ, Malembeka G, Clayton M. Imprisoned and imperiled: access to HIV and TB prevention and treatment, and denial of human rights, in Zambian prisons. J Int AIDS Soc. 2011;14:8.PubMedPubMedCentralCrossRef
28.
Rubenstein LS, Amon JJ, McLemore M, Eba P, Dolan K, Lines R, Beyrer C. HIV, prisoners, and human rights. The Lancet. 2016;388(10050):1202–14.CrossRef
29.
Kibret GD, Ferede A, Leshargie CT, Wagnew F, Ketema DB, Alebel A. Trends and spatial distributions of HIV prevalence in Ethiopia. Infect Dis Poverty. 2019;8(1).
30.
Fuge TG, Ayanto SY. Prevalence of smear positive pulmonary tuberculosis and associated risk factors among prisoners in Hadiya Zone prison, southern Ethiopia. BMC Res Notes. 2016;9(1):201.PubMedPubMedCentralCrossRef
31.
Fuge TG, Tsourtos G, Miller ER. Various structural factors influenced early antiretroviral therapy initiation amongst HIV infected prisoners: a qualitative exploration in South Ethiopia. BMC Public Health. 2021;21(1):1463.PubMedPubMedCentralCrossRef
32.
Southern Nations Nationalities and People’s Region (SNNPR). Prison Administration. Unpublished data on number of prisoners in SNNPR. 2020.
33.
Cleary M, Horsfall J, Hayter M. Data collection and sampling in qualitative research: does size matter? J Adv Nurs. 2014;70(3):473–5.PubMedCrossRef
34.
Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42(5):533–44.PubMedPubMedCentralCrossRef
35.
Moen K, Middelthon A-L. Qualitative research methods. In: Laake P, Benestad HB, Olsen BR, editors. Research in medical and biological sciences. 2nd ed. Amsterdam: Academic Press; 2015. pp. 321–78.CrossRef
36.
Gill P, Stewart K, Treasure E, Chadwick B. Methods of data collection in qualitative research: interviews and focus groups. Br Dent J. 2008;204(6):291–5.PubMedCrossRef
37.
Giorgi A. The descriptive phenomenological psychological method. J Phenomenological Psychol. 2012;43(1):3–12.CrossRef
38.
Giorgi A, Giorgi B, Morley J. The descriptive phenomenological psychological method. In: Willig and Rogers, editors.The SAGE handbook of qualitative research in psychology. 2nd ed. SAGE Publications; 2017. p. 176– 92.
39.
QSR International. NVivo qualitative data analysis software. 12 ed. Doncaster, Australia: QSR International Pty Ltd,; 2018.
40.
Dodgson JE. Reflexivity in qualitative research. J Hum Lactation. 2019;35(2):220–2.CrossRef
41.
Maxwell J. Designing a qualitative study. In: Bickman L, Rog D. J, editors. The SAGE handbook of applied social research methods. 3rd ed. Thousand Oaks: SAGE Publications; 2009. pp. 214–53.CrossRef
42.
Paley J. Phenomenology as qualitative research: a critical analysis of meaning attribution. New York: Routledge; 2017. p. 197.
43.
Holmes ADG. Researcher positionality - a consideration of its influence and place in qualitative research - a new researcher guide. Shanlax Int J Educ. 2020;8(4):1–10.CrossRef
44.
Kalyani T. Practicing Reflexivity: Balancing multiple positionalities during fieldwork. SAGE Research Methods Cases. 2. London, UK: SAGE Publications; 2019.
45.
Fazel S, Baillargeon J. The health of prisoners. The Lancet. 2011;377(9769):956–65.CrossRef
46.
World Health Organization (WHO)-. Regional office for Europe. Prisons and health. Copenhagen, Denmark: WHO; 2014.
47.
United Nations Office for Drugs and Crime (UNODC). HIV prevention, treatment and care in prisons and other closed settings: a comprehensive package of interventions. Vienna, Austria: UNODC; 2013.
48.
Zaller N, Thurmond P, Rich JD. Limited spending: an analysis of correctional expenditures on antiretrovirals for HIV-infected prisoners. Public Health Rep. 2007;122(1):49–54.PubMedPubMedCentralCrossRef
49.
Telisinghe L, Hippner P, Churchyard GJ, Gresak G, Grant AD, Charalambous S, Fielding KL. Outcomes of on-site antiretroviral therapy provision in a South African correctional facility. Int J STD AIDS. 2016;27(13):1153–61.PubMedCrossRef
50.
Mpawa H, Kwekwesa A, Amberbir A, Garone D, Divala OH, Kawalazira G, et al. Virological outcomes of antiretroviral therapy in Zomba central prison, Malawi; a cross-sectional study. J Int AIDS Soc. 2017;20(1):21623.PubMedPubMedCentralCrossRef
51.
Telisinghe L, Charalambous S, Topp SM, Herce ME, Hoffmann CJ, Barron P, et al. HIV and Tuberculosis in prisons in sub-saharan Africa. The Lancet. 2016;388(10050):1215–27.CrossRef
52.
Reid SE, Topp SM, Turnbull ER, Hatwiinda S, Harris JB, Maggard KR, et al. Tuberculosis and HIV control in sub-saharan African prisons: thinking outside the prison cell. J Infect Dis. 2012;205(2):265.CrossRef
53.
Emanuele P. Antiretroviral treatment in correctional facilities. HIV Clin Trial. 2005;6(1):25–37.CrossRef
54.
United Nations Office on Drugs and Crime (UNODC). Policy brief: HIV testing and counselling in prisons and other closed settings. Vienna, Austria: UNODC; 2009.
55.
Sprague C, Scanlon ML, Radhakrishnan B, Pantalone DW. The HIV prison paradox: Agency and HIV-positive women’s experiences in jail and prison in Alabama. Qual Health Res. 2017;27(10):1427–44.PubMedCrossRef
56.
Zack B. HIV prevention: behavioral interventions in correctional settings. In: Greifinger RB, editor. Public health behind bars; from prisons to communities. New York, USA: Springer; 2007. pp. 156–73.CrossRef
57.
Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS ONE. 2010;5(4):e10340.PubMedPubMedCentralCrossRef
58.
Paparizos V, Kourkounti S, Leuow K, Georgoulas S, Kyriakis K, Antoniou C. Adherence to antiretroviral therapy among HIV-infected prisoners. Le Infezioni in Medicina. 2013;21(3):189–93.PubMed
59.
The Federal Democratic Republic of Ethiopia Ministry of Health (FMH). National guidelines for HIV/AIDS and nutrition in Ethiopia. Addis Ababa, Ethiopia: FMH; 2008.
60.
Lucas KD, Eckert V, Behrends CN, Wheeler C, MacGowan RJ, Mohle-Boetani JC. Evaluation of routine HIV opt-out screening and continuum of care services following entry into eight prison reception centers–California, 2012. Morbidity & Mortality Weekly Report. 2016;65(7):178–81.CrossRef
61.
Meyer JP, Cepeda J, Taxman FS, Altice FL. Sex-related disparities in criminal justice and HIV treatment outcomes: a retrospective cohort study of HIV-infected inmates. Am J Public Health. 2015;105(9):1901–10.PubMedPubMedCentralCrossRef
62.
Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. Jornal of American Medical Association, Internal Medicine. 2014;174(5):721-9.
63.
Metadata
Title
Imprisonment for South Ethiopian people living with HIV presents a double health burden: lived experiences of prisoners
Authors
Terefe Gone Fuge
George Tsourtos
Emma R Miller
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2024
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-024-10587-y

Other articles of this Issue 1/2024

BMC Health Services Research 1/2024 Go to the issue

Research

Factors influencing contracting of residents with family doctors in China: a national cross-sectional survey

Research

“So at least now I know how to deal with things myself, what I can do if it gets really bad again”—experiences with a long-term cross-sectoral advocacy care and case management for severe multiple sclerosis: a qualitative study

Research

Influence of inventory management practices on the availability of emergency obstetric drugs in Rwandan public hospitals: a case of Rwanda Southern Province

Research

The impacts of national centralized drug procurement policy on drug utilization of medical institutions: an empirical study in a county-level hospital in China

Research

Inpatient healthcare utilization among people with disabilities in Iran: determinants and inequality patterns

Correction

Correction: Health professionals’ experience and perceived obstacles with managing patients’ medication information in Norway: cross-sectional survey